Cargando…
Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice
PURPOSE: To study the effect of oxidation on the structure of recombinant human interferon beta-1a (rhIFNβ-1a) and its immunogenicity in wild-type and immune-tolerant transgenic mice. METHODS: Untreated rhIFNβ-1a was degraded by metal-catalyzed oxidation, H(2)O(2)-mediated oxidation, and guanidine-m...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170469/ https://www.ncbi.nlm.nih.gov/pubmed/21544687 http://dx.doi.org/10.1007/s11095-011-0451-4 |
_version_ | 1782211629930250240 |
---|---|
author | van Beers, Miranda M. C. Sauerborn, Melody Gilli, Francesca Brinks, Vera Schellekens, Huub Jiskoot, Wim |
author_facet | van Beers, Miranda M. C. Sauerborn, Melody Gilli, Francesca Brinks, Vera Schellekens, Huub Jiskoot, Wim |
author_sort | van Beers, Miranda M. C. |
collection | PubMed |
description | PURPOSE: To study the effect of oxidation on the structure of recombinant human interferon beta-1a (rhIFNβ-1a) and its immunogenicity in wild-type and immune-tolerant transgenic mice. METHODS: Untreated rhIFNβ-1a was degraded by metal-catalyzed oxidation, H(2)O(2)-mediated oxidation, and guanidine-mediated unfolding/refolding. Four rhIFNβ-1a preparations with different levels of oxidation and aggregation were injected intraperitoneally in mice 15× during 3 weeks. Both binding and neutralizing antibodies were measured. RESULTS: All rhIFNβ-1a preparations contained substantial amounts of aggregates. Metal-catalyzed oxidized rhIFNβ-1a contained high levels of covalent aggregates as compared with untreated rhIFNβ-1a. H(2)O(2)-treated rhIFNβ-1a showed an increase in oligomer and unrecovered protein content by HP-SEC; RP-HPLC revealed protein oxidation. Guanidine-treated rhIFNβ-1a mostly consisted of dimers and oligomers and some non-covalent aggregates smaller in size than those in untreated rhIFNβ-1a. All degraded samples showed alterations in tertiary protein structure. Wild-type mice showed equally high antibody responses against all preparations. Transgenic mice were discriminative, showing elevated antibody responses against both metal-catalyzed oxidized and H(2)O(2)-treated rhIFNβ-1a as compared to untreated and guanidine-treated rhIFNβ-1a. CONCLUSIONS: Oxidation-mediated aggregation increased the immunogenicity of rhIFNβ-1a in transgenic mice, whereas aggregated preparations devoid of measurable oxidation levels were hardly immunogenic. |
format | Online Article Text |
id | pubmed-3170469 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-31704692011-09-26 Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice van Beers, Miranda M. C. Sauerborn, Melody Gilli, Francesca Brinks, Vera Schellekens, Huub Jiskoot, Wim Pharm Res Article PURPOSE: To study the effect of oxidation on the structure of recombinant human interferon beta-1a (rhIFNβ-1a) and its immunogenicity in wild-type and immune-tolerant transgenic mice. METHODS: Untreated rhIFNβ-1a was degraded by metal-catalyzed oxidation, H(2)O(2)-mediated oxidation, and guanidine-mediated unfolding/refolding. Four rhIFNβ-1a preparations with different levels of oxidation and aggregation were injected intraperitoneally in mice 15× during 3 weeks. Both binding and neutralizing antibodies were measured. RESULTS: All rhIFNβ-1a preparations contained substantial amounts of aggregates. Metal-catalyzed oxidized rhIFNβ-1a contained high levels of covalent aggregates as compared with untreated rhIFNβ-1a. H(2)O(2)-treated rhIFNβ-1a showed an increase in oligomer and unrecovered protein content by HP-SEC; RP-HPLC revealed protein oxidation. Guanidine-treated rhIFNβ-1a mostly consisted of dimers and oligomers and some non-covalent aggregates smaller in size than those in untreated rhIFNβ-1a. All degraded samples showed alterations in tertiary protein structure. Wild-type mice showed equally high antibody responses against all preparations. Transgenic mice were discriminative, showing elevated antibody responses against both metal-catalyzed oxidized and H(2)O(2)-treated rhIFNβ-1a as compared to untreated and guanidine-treated rhIFNβ-1a. CONCLUSIONS: Oxidation-mediated aggregation increased the immunogenicity of rhIFNβ-1a in transgenic mice, whereas aggregated preparations devoid of measurable oxidation levels were hardly immunogenic. Springer US 2011-05-05 2011 /pmc/articles/PMC3170469/ /pubmed/21544687 http://dx.doi.org/10.1007/s11095-011-0451-4 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Article van Beers, Miranda M. C. Sauerborn, Melody Gilli, Francesca Brinks, Vera Schellekens, Huub Jiskoot, Wim Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice |
title | Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice |
title_full | Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice |
title_fullStr | Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice |
title_full_unstemmed | Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice |
title_short | Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice |
title_sort | oxidized and aggregated recombinant human interferon beta is immunogenic in human interferon beta transgenic mice |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170469/ https://www.ncbi.nlm.nih.gov/pubmed/21544687 http://dx.doi.org/10.1007/s11095-011-0451-4 |
work_keys_str_mv | AT vanbeersmirandamc oxidizedandaggregatedrecombinanthumaninterferonbetaisimmunogenicinhumaninterferonbetatransgenicmice AT sauerbornmelody oxidizedandaggregatedrecombinanthumaninterferonbetaisimmunogenicinhumaninterferonbetatransgenicmice AT gillifrancesca oxidizedandaggregatedrecombinanthumaninterferonbetaisimmunogenicinhumaninterferonbetatransgenicmice AT brinksvera oxidizedandaggregatedrecombinanthumaninterferonbetaisimmunogenicinhumaninterferonbetatransgenicmice AT schellekenshuub oxidizedandaggregatedrecombinanthumaninterferonbetaisimmunogenicinhumaninterferonbetatransgenicmice AT jiskootwim oxidizedandaggregatedrecombinanthumaninterferonbetaisimmunogenicinhumaninterferonbetatransgenicmice |